These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 3075553)

  • 21. Comparative clinical pharmacology of human insulin (Novo) and porcine insulin in normal subjects.
    Ebihara A; Kondo K; Ohashi K; Kosaka K; Kuzuya T; Matsuda A
    Diabetes Care; 1983; 6 Suppl 1():17-22. PubMed ID: 6343032
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pharmacokinetics of the rapid-acting insulin analog, insulin aspart, in rats, dogs, and pigs, and pharmacodynamics of insulin aspart in pigs.
    Plum A; Agerso H; Andersen L
    Drug Metab Dispos; 2000 Feb; 28(2):155-60. PubMed ID: 10640512
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Variation of insulin absorption during subcutaneous and peritoneal infusion in insulin-dependent diabetic patients with unsatisfactory long-term glycaemic response to continuous subcutaneous insulin infusion.
    Wredling R; Liu D; Lins PE; Adamson U
    Diabete Metab; 1991; 17(5):456-9. PubMed ID: 1752346
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Chronic intraperitoneal insulin delivery, as compared with subcutaneous delivery, improves hepatic glucose metabolism in streptozotocin diabetic rats.
    Mason TM; Gupta N; Goh T; El-Bahrani B; Zannis J; van de Werve G; Giacca A
    Metabolism; 2000 Nov; 49(11):1411-6. PubMed ID: 11092503
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Insulin levels after portal and systemic insulin infusion differ in a dose-dependent fashion.
    De Vos P; De Haan BJ; Vegter D; Hillebrands JL; Strubbe JH; Bruggink JE; Van Schilfgaarde R
    Horm Metab Res; 1998 Dec; 30(12):721-5. PubMed ID: 9930629
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Control of diabetes through a subcutaneous peritoneal access device (SPAD) in patients with resistance to subcutaneously injected insulin.
    Dandona P; Fonseca V; Fernando O; Menon RK; Weerakoon J; Kurtz A; Stephen R
    Diabetes Res; 1987 May; 5(1):47-9. PubMed ID: 3304785
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Bioactivity and pharmacokinetics of human proinsulin in comparison to human insulin after intravenous and subcutaneous injection.
    Schatz H; Ammermann S; Laube H; Federlin K
    Horm Metab Res; 1988 Jul; 20(7):445-9. PubMed ID: 3049293
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Route of administration as a factor in the selectivity of hormone suppression of a somatostatin analog in rats.
    Lien EL; Garsky VM
    Horm Metab Res; 1981 Dec; 13(12):675-8. PubMed ID: 6119282
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Differential metabolic responses to tumor necrosis factor with increase in age.
    Mondon CE; Starnes HF
    Metabolism; 1992 Sep; 41(9):970-81. PubMed ID: 1518426
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Influence of insulin infusion kinetics of an artificial beta cell on blood glucose control in insulin-dependent diabetics.
    Kerner W; Beischer W; Maier V; Pfeiffer EF
    Horm Metab Res Suppl; 1979; (8):71-80. PubMed ID: 395094
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison of pharmacokinetic and pharmacodynamic properties of single-dose oral insulin spray and subcutaneous insulin injection in healthy subjects using the euglycemic clamp technique.
    Cernea S; Kidron M; Wohlgelernter J; Modi P; Raz I
    Clin Ther; 2004 Dec; 26(12):2084-91. PubMed ID: 15823772
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tracer kinetic studies of glucose and alanine metabolism in diabetic dogs on the artificial beta cell.
    Freyse EJ; Fischer U; Albrecht G
    Biomed Biochim Acta; 1984; 43(5):607-14. PubMed ID: 6477544
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of peripheral and portal venous insulin administration on postprandial metabolic responses in alloxan-diabetic dogs. Effects of identical preprogrammed complex insulin infusion waveforms.
    Fischer U; Rizza RA; Hall LD; Westland RE; Haymond MW; Clemens AH; Gerich JE; Service FJ
    Diabetes; 1982 Jul; 31(7):579-84. PubMed ID: 7160538
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The effect of prehepatic insulin administration on alanine flux rates in diabetic dogs.
    Freyse EJ; Fischer U; Albrecht G; Marx S; Keilacker H
    Diabetologia; 1987 Jun; 30(6):402-8. PubMed ID: 3315797
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Peritoneal and subcutaneous absorption of insulin in type I diabetic subjects.
    Giacca A; Caumo A; Galimberti G; Petrella G; Librenti MC; Scavini M; Pozza G; Micossi P
    J Clin Endocrinol Metab; 1993 Sep; 77(3):738-42. PubMed ID: 8370695
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of intraperitoneal, intraportal and intravenous insulin infusion.
    Poulsen JS; Smith M; Deckert M; Deckert T
    Acta Endocrinol (Copenh); 1980 Dec; 95(4):500-4. PubMed ID: 7006290
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Long-term ambulatory peritoneal insulin infusion of brittle diabetes with portable pumps: comparison with intravenous and subcutaneous routes.
    Selam JL; Slingeneyer A; Hedon B; Mares P; Beraud JJ; Mirouze J
    Diabetes Care; 1983; 6(2):105-11. PubMed ID: 6406198
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Intravenous insulin infusion to simulate subcutaneous absorption. Bioavailability and metabolic sequelae.
    Watanabe RM; Vølund A; Bergman RN
    Diabetes Care; 1991 Nov; 14(11):1021-30. PubMed ID: 1797482
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Determination of portal insulin absorption from peritoneum via novel nonisotopic method.
    Selam JL; Bergman RN; Raccah D; Jean-Didier N; Lozano J; Charles MA
    Diabetes; 1990 Nov; 39(11):1361-5. PubMed ID: 2227110
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison of the effectiveness of various routes of insulin injection: insulin levels and glucose response in normal subjects.
    Guerra SM; Kitabchi AE
    J Clin Endocrinol Metab; 1976 May; 42(5):869-74. PubMed ID: 1270578
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.